Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection: Rationale and Clinical Trial Evidence

Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756284818786108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Tenofovir and Its Potential in the Treatment of Hepatitis B Virus

Therapeutics and Clinical Risk Management
2009English

Treatment of Chronic Hepatitis B Virus Infection With Rebavrin.

BMJ
1977English

Points: Antiviral Treatment in Chronic Infection With Hepatitis B Virus

BMJ
1986English

Renal Concerns in the Treatment of Chronic Hepatitis B With Tenofovir

Journal of Renal and Hepatic Disorders
2017English

Letter: Distinct Hepatitis B Virus Relapse Rates After Discontinuing Tenofovir and Entecavir Therapy in Chronic Hepatitis B Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2020English

Tenofovir Treatment of the Severe Acute Hepatitis B

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2013English

Boceprevir in the Treatment of Chronic Hepatitis C Virus Infection

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Recombinant Human Interleukin 2 Treatment in Patients With Chronic Hepatitis B Virus Infection.

Japanese Journal of Clinical Immunology
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy